- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02968225
Using Serious Game Technology to Improve Sensitivity to Eye Gaze in Autism (SAGA)
March 3, 2021 updated by: K. Suzanne Scherf, Penn State University
The investigators hypothesize that this serious game (designed to provide a learning environment that maximizes opportunities for adolescents with autism to discover the functional utility of eye gaze) will improve sensitivity to eye gaze cues, specifically to identify gazed-at objects, and will also lead to increased social attention to faces in adolescents with autism.
The investigators will test this hypothesis in a small-scale exploratory randomized control trial that will include both behavioral and eye tracking outcome measures.
Study Overview
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
University Park, Pennsylvania, United States, 16802
- Pennsylvania State University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 years to 14 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion criteria:
- parent/caregiver of an adolescent with a diagnosis of ASD,
- parent/caregiver and adolescent with ASD both native English speakers,
- adolescent with ASD aged between 10-18 years at enrollment,
- adolescent has normal vision and hearing with correction as indicated by parent report,
- adolescent is able to use a computer for the purposes of game play,
- adolescent scores > 80% correct (i.e., 0.5 SD less than M of TD adolescents) on online eye gaze screening task,
- ASD diagnosis of adolescent confirmed in lab via the Autism Diagnostic Observation Schedule,
- Full Scale IQ of adolescent determined to be between 70-130 on the Kaufman Brief Intelligence Test,
- reading ability of adolescent determined to be at least a second grade level as assessed by the Oral and Written Language Scales,
- adolescent is capable of cooperating with testing,
- parent/caregiver and adolescent both consent/assent to participate in the research.
Exclusion Criteria
- adolescent has had seizures within the previous two years,
- family lacks stable home internet,
- parent or adolescent refuses to consent/assent to take part in the research,
- adolescent is 18 and has a legal guardian, prohibiting him/her from legally consenting, or
- adolescent is 18 and cannot understand the consent (i.e., fails consent quiz).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Computer Game
All Computer Game participants will complete:
|
The game involves viewing subtle nonverbal behaviors of game characters for the purpose of executing their own goal-directed behavior in the game related to solving various crimes.
The learning involves interpreting nonverbal cues on the animated characters, such as pointing, head turns, eye gaze cues.
|
|
No Intervention: Waitlist control
All Treatment as usual control participants will complete:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Static Eye Gaze Following Task
Time Frame: 2 months
|
Eye tracking and accuracy
|
2 months
|
|
Dynamic Eye Gaze Following Task
Time Frame: 2 Months
|
Eye tracking and accuracy
|
2 Months
|
|
Social/Visual Attention Task
Time Frame: 2 Months
|
Eye tracking
|
2 Months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Social Responsiveness Scale
Time Frame: 2 months
|
Parents completing measure of autism-like behavior in adolescents
|
2 months
|
|
Social Skills Inventory System - Child version
Time Frame: 2 months
|
Adolescents completing measure of social skills and problem behaviors in themselves
|
2 months
|
|
Social Skills Inventory System - Adult version
Time Frame: 2 months
|
Parents completing measure of social skills and problem behaviors in adolescents
|
2 months
|
|
Treatment as Usual
Time Frame: 2 months
|
Parents reporting on social and behavioral treatments adolescents receiving in and out of school
|
2 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Suzy Scherf, PhD, Penn State University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2016
Primary Completion (Actual)
October 1, 2018
Study Completion (Actual)
October 1, 2018
Study Registration Dates
First Submitted
November 16, 2016
First Submitted That Met QC Criteria
November 17, 2016
First Posted (Estimate)
November 18, 2016
Study Record Updates
Last Update Posted (Actual)
March 5, 2021
Last Update Submitted That Met QC Criteria
March 3, 2021
Last Verified
March 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R61MH110624 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
IPD Plan Description
The data will be shared in the NIMH National Data Archive
IPD Sharing Supporting Information Type
- Study Protocol
- Informed Consent Form (ICF)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.